(1) I have chosen to focus my TBL AE on the section of the Introductory Microeconomics text, CoreMicroeconomics, 3rd Edition by Eric P. Chiang (formerly by Gerald W. Stone) that covers the inefficiency associated with monopoly profit maximizing behavior. The stated SLO is to “describe the differences between monopoly and competition” (Chiang 2014, p. 216), the latter of which I interpret more specifically as the ability to delineate and evaluate the economic benefits and economic costs of monopoly vs. competition and consider appropriate policy action” The core concept that I want the students to understand is that monopoly profit maximizing behavior (or any sustained market power-based rent seeking) results in a dead weight loss from too little of the product being produced and sold. However, it is the promise of short term monopoly rents that incentivize risk-taking, research and new product development, and innovation. Thus, policy should seek to minimize DWL while maintaining the economic rationale for innovation.
While no single question at the of the chapter associates fully with this topic, one question provides a brief statement on a price-fixing anti-trust case in the LCD panel industry that involved Toshiba, Samsung, and Sharp. The question asks students, “What potential benefits to companies gain by working together to fix prices on a good?” (Chiang 2014, p. 241) A second, more technical question, provides a MR/D/MC/ATC graph and asks the students to demonstrate competitive market price and quantity, monopoly price and quantity, and DWL on that graph. (Chiang 2014, p. 241)
(2) As a TBL AE, these two questions taken together are only moderately effective when measured against the 4-Ss. While the question does draw upon an actual anti-trust scenario, it is not one that is likely to be familiar or relevant to students – thereby failing short on the significance criterion. Further, the question is open ended, not allowing for specific choice, so that even if applied in a simultaneous report setting in which all groups worked on the same question, it would not necessarily produce the desired debate because students would not share a common set of response options (FYI – this is something that I like about the assigned TBL framework, and not something that I currently do in my own flipped classes).
(3) I would revise the question by using a more current and well-reported upon example of monopoly power (I often draw upon NY Times “Upshot” articles for this purpose). In this case, I was torn between using taxi medallions in the era of Uber and Lyft and using drug pricing debates such as the well-reported Epi-Pen issue from a few years ago. In the end, I decided upon the latter. My proposed AE is as follows:
Pre-class preparation (The student knowledge base):
In addition to reading the above articles, students will have watched videos or read text explaining the profit maximizing behavior of monopoly firms and how that behavior leads to a different outcome than is observed under competitive situations due to the downward sloping MR faced by the monopolist. The nature of the resulting dead weight loss will have been covered. Understanding of these concepts would have been covered through a multiple choice quiz taken in advance of the class period. Further, in previous classes, the students would have been exposed to concepts of ATC and profit.
Prefatory remarks (I would attempt to convey this in introducing the exercise):
Concern over rising drug prices such as the drastic increase in Epi-Pen pricing noted in 2016 and the more recent Humira case described in the first NY Times article read for class (
https://nyti.ms/2F3P665) has called into question the advisability of pharmaceutical drug patenting given the monopoly power and economic dead weight loss that results from those patents. However, patents can serve an important role according to the second NY Times article (
http://nyti.ms/1Z84CkB) on drug shortages read for class. Today we consider the insight that microeconomic theory provides on development of an appropriate policy response to this problem.
AE: Pharmaceutical Patenting
Which of the following possible policy actions do you think is most likely to improve the long term well-being of consumers in need of pharmaceutical products, and why? Your rationale should include reference to the monopoly graph from the iRAT/tRAT.
a. Disallow any further pharmaceutical patenting as patents are allowing pharmaceutical companies to earn economic profits at
the expense of those in need of medication.
b. Allow continued patenting, but force pharmaceutical companies to set fair prices by imposing a price ceiling set at the
competitive market price.
c. Allow continued patenting, but force pharmaceutical companies to offer discounted pricing / rebates to low income
individuals or individuals without access to insurance.
d. Have the government pay for all pharmaceutical research and development instead of providing patents to those companies.
Questions to guide student reporters (I would seek to have students touch upon the following in their reporting/debates):
1. What does the patenting allow and why?
2. How/where do we see the firm behavior associated with patenting on the monopoly graph?
3. What is the problem associated with the patenting? (i.e., Is profit the problem, or is it something else?) Who is hurt by
the monopoly behavior and how are they hurt?
4. How/where do we see the problem associated with patenting on the monopoly graph?
5. Can/will the market correct itself? Why or why not?
6. Why would the government provide patents in the first place? Do they serve any social purpose?
7. What might happen in the industry if there were no patents? Why would this happen?
8. How/where do we see the need for patenting on the monopoly graph? Are monopolists guaranteed profit?